| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell and Tumor Biology |
Department of Oncology, Albert Einstein Cancer Center, Montefiore Medical Center, Bronx, New York
Requests for reprints: Barbara G. Heerdt, Department of Oncology, Albert Einstein Cancer Center, Montefiore Medical Center, 111 East 210th Street, Bronx, NY 10467. Phone: 718-920-2750; Fax: 718-882-4464; E-mail: heerdt{at}aecom.yu.edu.
We subcloned cell lines from SW620 cells establishing that, despite the dynamic nature of the mitochondrial membrane potential (
m), there are significant and stable differences in the intrinsic 
m among cells within an in vitro population of human colonic carcinoma cells. Whereas more dramatic differences in 
m would likely perturb essential mitochondrial functions, the differences in 
m of the subclones did not affect steady-state reactive oxygen species levels, electron transport activity, or cellular viability and growth rates. However, the differences in intrinsic 
m had a significant effect on the tumorigenic behavior of the cells. Subcloned cell lines with higher 
m were more likely to exhibit elevated steady-state levels of vascular endothelial growth factor and matrix metalloproteinase 7, and increased invasive behavior (properties associated with tumor progression), than cells with lower intrinsic 
m, whereas cells with lower 
m were more likely to respond to the chemopreventive activities of butyrate, including 
m dissipation, growth arrest, and apoptosis, than cells with higher 
m. Therefore, these data establish that the probability for tumor development and progression is linked to stable differences in the intrinsic 
m of colonic epithelial cells.
This article has been cited by other articles:
![]() |
C. V. Pereira, N. G. Machado, and P. J. Oliveira Mechanisms of Berberine (Natural Yellow 18)-Induced Mitochondrial Dysfunction: Interaction with the Adenine Nucleotide Translocator Toxicol. Sci., October 1, 2008; 105(2): 408 - 417. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Michelakis, M. R. Wilkins, and M. Rabinovitch Emerging Concepts and Translational Priorities in Pulmonary Arterial Hypertension Circulation, September 30, 2008; 118(14): 1486 - 1495. [Full Text] [PDF] |
||||
![]() |
M. M. Jellicoe, S. J. Nichols, B. A. Callus, M. V. Baker, P. J. Barnard, S. J. Berners-Price, J. Whelan, G. C. Yeoh, and A. Filipovska Bioenergetic differences selectively sensitize tumorigenic liver progenitor cells to a new gold(I) compound Carcinogenesis, June 1, 2008; 29(6): 1124 - 1133. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bonnet, G. Rochefort, G. Sutendra, S. L. Archer, A. Haromy, L. Webster, K. Hashimoto, S. N. Bonnet, and E. D. Michelakis The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted PNAS, July 3, 2007; 104(27): 11418 - 11423. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Heerdt, M. A. Houston, and L. H. Augenlicht Growth Properties of Colonic Tumor Cells Are a Function of the Intrinsic Mitochondrial Membrane Potential Cancer Res., February 1, 2006; 66(3): 1591 - 1596. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |